Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RBM15B | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ZCCHC3 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | DBR1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | CASP8AP2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | BLMH | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | RNPS1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | RPF2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | RABAC1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
mRNA | ARID1A | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | CPEB2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |